Transplantation

No Preference

Tolerance Induction with Hematopoietic Stem Cell for Kidney Transplantation

Friday, June 16
6:15 PM - 7:30 PM

Tolerance induction is considered to be a final goal in the field of organ transplantation. We have performed simultaneous bone marrow and kidney transplantation in MHC mismatched patients to induce transient mixed chimerism and donor-specific tolerance. From December 2011 to May 2014, seven MHC mismatched patients received simultaneous bone marrow and kidney transplantation. Median follow-up was 34 months after transplant.


The preconditioning regimen consisted of cyclophosphamide, fludarabine, rituximab (375mg/m2, -7 and -2 days before transplantation), antithymocyte globulin (1.5mg/mg/day,-2~0 days) and thymic irradiation. Maintenance immunosuppressions were tacrolimus and steroids.


Immunosuppression tapering was usually initiated when the patient sustained stable graft function for at least 12 months post-transplant. Immunosuppression was slowly tapered over 6~12 months. Four out of the seven patients were successfully tapered off immunosuppression. One patient is currently undergoing immunosuppression tapering. Two patients failed at immunosuppression withdrawal; Because of acute rejection and severe BK virus nephritis. 5 patients experienced BK viremia during their post-transplant period.


We analyzed T cell reconstitution after bone marrow and kidney transplantation, showed a major expansion of CD8+ effector memory (CD45RA-CCR7-), end-stage effector (CD45RA+CCR7-) T cells, and late-differentiated CD27-CD28- cells. We screened BMTKT patients for the expression of an inhibitory receptor such as PD-1, 2B4, CD160, BTLA, TIGIT, Tim-3 and LAG-3. They were increased an expression of 2B4 and PD-1. And, we analyzed the functionally distinct subpopulations in regulatory T cells. Patients with experienced acute cellular rejection were more elevated CD45RA-Foxp3low non-suppressive Treg cells (Fr-III) than CD45RA-Foxp3high effector Treg cells (Fr-II).


We have performed seven cases of simultaneous bone marrow and kidney transplantation in MHC mismatched patients. Four out of the seven patients achieved immunosuppression withdrawal and revealed increased CD45RA-Foxp3high effector Treg cells (Fr-II).

Hyojun Park

Instructor
Samsung Medical Center

Presentation(s):

    Send Email for Hyojun Park

    Yeongbeen Kwon

    2Transplantation Research Center, Samsung Biomedical Research Institute, Samsung Medical Center, Seoul , Korea

    Presentation(s):

      Send Email for Yeongbeen Kwon

      Sung Joo Kim

      professor
      1Department of Surgery, Samsung Medical Center,Sungkyunkwan University School of Medicine, Seoul , Korea

      Presentation(s):

        Send Email for Sung Joo Kim


        Assets

        Tolerance Induction with Hematopoietic Stem Cell for Kidney Transplantation



        Attendees who have favorited this

        Send Email for Tolerance Induction with Hematopoietic Stem Cell for Kidney Transplantation